Project Grant R01CA301632
Award Date
4/1/25
Completion Date
3/31/30
Dollars Obligated
$647K
Federal Agency
National Cancer Institute
Federal Grant Program
93.396
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The Department of Health and Human Services' National Cancer Institute (NCI) awarded a $278,250 Project Grant under the Cancer Research Manpower program (CFDA 93.398) to the Sloan-Kettering Institute for Cancer Research in New York. The grant will support research to investigate the "Crosstalk Between Obesity-Induced Fatty Liver and Liver Metastasis" over a 1-year period from July 2024 to July 2025. The research aims to examine how obesity-related non-alcoholic fatty liver disease...
This federal Project Grant award from the National Institutes of Health's National Cancer Institute (CFDA 93.396 Cancer Biology Research) provides $2,397,277 to the Sanford Burnham Prebys Medical Discovery Institute to conduct research on the role of metabolic stress and hypernutrition in the progression from non-alcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC).
The key products and services to be delivered under this 5-year award include:
Investigating how the NRF2-FBP1...
The National Cancer Institute (CFDA 93.396 - Cancer Biology Research) awarded Loyola University of Chicago a $461,844 project grant titled "Hyperpolarized 13C Metabolic Imaging of Tumorigenesis in the Liver". The objective is to use novel hyperpolarized 13C probes to image glycolysis, a critical pathway in hepatocellular carcinoma (HCC) development, and establish in vivo imaging biomarkers to assess altered liver metabolism during HCC progression. The project aims to synthesize a...
This $577,034 federal Project Grant award from the National Cancer Institute's Cancer Biology Research program (CFDA 93.396) will support research by the Sloan-Kettering Institute for Cancer Research on the role of cancer cell mechanics and the tumor microenvironment in metastasis and immunosurveillance. The key objectives are to:
Examine how distinct metastatic microenvironments affect cancer cell biomechanics and immune vulnerability in mouse models and human samples.
Determine if...
This $213,284 Project Grant was awarded by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. The grant supports research by the Beckman Research Institute of the City of Hope to develop novel inhibitors targeting the CYP8B1 protein, which plays a key role in the development of obesity-associated hepatocellular carcinoma (HCC).
The research aims to determine the role of CYP8B1 in obesity-associated HCC and to develop potent, selective...
This award provides funding for research into the relationship between inflammatory signaling in the leptomeninges (the membranes surrounding the brain and spinal cord) and the growth of leptomeningeal metastases, a lethal complication of cancer. The award is a $730,398 Project Grant funded by the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396). The research is being conducted by the Sloan-Kettering Institute for Cancer Research, a non-profit organization in...
This $544,475 Project Grant awarded by the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) supports the development and validation of a novel in vitro cancer metastasis model system using decellularized organ tissues, or "biomatrices." The primary objectives are to:
Generate a comprehensive panel of biomatrices representing common sites of cancer metastasis (e.g. liver, lung) to recapitulate organ-specific tumor biology and treatment response.
Demonstrate the...
The National Cancer Institute (NCI) awarded a $676,584 Project Grant under the Cancer Biology Research program (CFDA 93.396) to The University of Texas MD Anderson Cancer Center. The 5-year grant, which began on April 1, 2025, will support research to investigate the co-evolution of cancer cell genomic alterations and their interactions with the tumor microenvironment during metastatic spread of triple-negative breast cancer (TNBC) to multiple organ sites.
The research project aims to...
This federal Project Grant award, valued at $1,224,644.00, was provided by the National Cancer Institute (NCI) under its Cancer Biology Research program (CFDA 93.396). The grant is focused on dissecting a novel tumor-promoting axis in intrahepatic cholangiocarcinoma (CCA), a highly desmoplastic and deadly type of bile duct cancer.
The key objectives of this 5-year project, awarded on August 13, 2024, are to: 1) Elucidate the molecular mechanisms by which the immune checkpoint protein B7-H4...
The National Cancer Institute (NCI) awarded a $436,472 R21 project grant to Cedars-Sinai Medical Center under the Cancer Detection and Diagnosis Research program (CFDA 93.394). The objective is to investigate the performance of novel circulating biomarker digital scores for evaluating treatment response in hepatocellular carcinoma (HCC) patients. The research leverages two technologies - an HCC extracellular vesicle digital scoring assay and the GALAD serum protein-based scoring system - to...